Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS
BRL in Millions, $ in Millions
12 Months Ended
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Dec. 31, 2013
USD ($)
Operating activities:      
Consolidated net income $ 434.8 $ 374.0 $ 359.9
Adjustments to reconcile consolidated net income to net cash provided by operating activities:      
Gain on divestitures 0.0 0.0 (19.0)
Impairment of cost method investment 14.8 0.0 17.0
Depreciation and amortization 200.0 204.2 190.3
Stock-based compensation expense 38.4 38.1 32.2
Excess tax benefits from stock-based compensation plans (30.0) (17.7) (14.6)
Deferred income taxes (28.7) (9.6) (9.7)
Changes in assets and liabilities, excluding effects of acquisitions:      
Accounts receivable, net (26.9) (27.8) (2.4)
Prepaid expenses and other current assets 10.8 (5.2) (4.2)
Other assets 5.1 (0.6) 7.1
Current liabilities, excluding debt 118.5 54.3 2.1
Other long-term liabilities, excluding debt 5.3 6.5 10.3
Cash provided by operating activities 742.1 616.2 569.0
Investing activities:      
Capital expenditures (146.2) (86.4) (83.3)
Acquisitions, net of cash acquired (4.4) (341.0) (91.4)
Cash received from divestitures 2.9 0.6 47.5
Investment in unconsolidated affiliates, net (0.1) (2.5) (9.1)
Cash used in investing activities (147.8) (429.3) (136.3)
Financing activities:      
Net short-term borrowings (repayments) (331.0) 379.9 (267.3)
Payments on long-term debt 0.0 (290.0) (15.0)
Treasury stock purchases (196.3) (301.6) (11.9)
Dividends paid to Equifax shareholders (137.8) (121.2) (106.7)
Dividends paid to noncontrolling interests (6.4) (7.9) (10.5)
Proceeds from exercise of stock options 34.4 39.7 47.8
Excess tax benefits from stock-based compensation plans 30.0 17.7 14.6
Contributions from noncontrolling interests 0.0 0.0 16.7
Debt issuance costs (4.9) 0.0 (0.8)
Cash (used in) provided by financing activities (612.0) (283.4) (333.1)
Effect of foreign currency exchange rates on cash and cash equivalents (17.3) (11.1) (10.5)
(Decrease) Increase in cash and cash equivalents (35.0) (107.6) 89.1
Cash and cash equivalents, beginning of period 128.3 235.9 146.8
Cash and cash equivalents, end of period $ 93.3 $ 128.3 $ 235.9